Clinical

Two head-to-head trials comparing the safety of Incruse Ellipta to 2 available bronchodilator treatments used by patients with chronic obstructive pulmonary disease has yielded positive results for GlaxoSmithKline's therapy.

The drug is awaiting an FDA verdict next week.

As the date for the comment period on the proposed guidance by HHS on 340B drug pricing draws near, read about the program and its impact on healthcare overall.

Published in JAMA Oncology, the study found a significant difference in quality and access to care for black patients diagnosed with localized prostate cancer.

Patients with cancer in the urology clinic at a VA hospital in Arizona may have suffered adverse outcomes due to clinical disconnect and staff shortage.

Patients with metastatic pancreatic cancer who have progressed on gemcitabine now have the option of Onivyde combined with leucovorin/fluorouracil.

A study published in the Journal of the American College of Surgeons found that including patients in the Enhanced Recovery program has a dramatic impact on their recovery post surgery.

A presentation at the annual meeting of the American Society for Radiation Oncology underscored the importance of patient-centered care and the benefit of incorporating the patient voice in advanced oncology care.

A letter published in JAMA Internal Medicine questions the FDA's acceptance of surrogate endpoints for what the authors describe as "costly, toxic drugs that do not improve overall survival."

A new evidence-based guidance update provided by the American Cancer Society, published yesterday in JAMA Internal Medicine, recommends a delay in initiating screening mammograms in women with an average risk of developing the disease.

A panel discussion at the PMC/BIO Solutions Summit in Washington, DC, saw an exchange on widespread and appropriate education of personalized medicine among payers, providers, patients, and families.

NCCN Evidence Blocks add affordability to Guidelines recommendations on safety, efficacy, quality, and consistency of regimens.

The results of a study published in The Lancet Infectious Diseases necessitate a wake-up call for stakeholders to develop a new approach that can overcome the rapidly-growing threat of antibiotic resistance.

Not just providers of care, but payers as well have been having a hard time embracing the rapidly-evolving and dynamic field of personalized medicine, according to panel members at the recently held PMC/BIO Solutions Summit.

There have been many studies proving that depression interferes with medication adherence, but it isn't enough to just treat depression to get better outcomes, providers have to hand hold patients and help them improve their motivation to start taking medications again, explained Paul Ciechanowski, MD, MPH, associate professor at the University of Washington.

The analysis by Anthem Inc, has identified a need for more widespread implementation of these interventions aimed at reducing healthcare utilization.

Patients are embracing and exploring alternatives to the traditional office practice, and the expansion of retail health clinics is a big part of that. However, the American College of Physicians said these clinics are best used as a backup alternative to a primary care physician.

The study, published in the New England Journal of Medicine failed to confirm epidemiologic and preclinical data that vitamin D and calcium can reduce the risk of colorectal neoplasia.

A panel discussion during the 2nd PMC/BIO Solutions Summit identified barriers and discussed the path forward to improve clinical integration of precision medicine.

The financial aftereffects of cancer have a tremendous impact on young adults as they move forward with their lives after treatment.

Updates on FDA approvals and extended indications for oncology drugs.

Evaluation of Prosigna's risk of relapse score as a predictor of response to multiagent neoadjuvant chemotherapy in HR+/HER2 breast cancer patients.

An update on recent progress in oncology managed care.

The American Society of Clinical Oncology has issued a statement asking for an improved evidence base for treating older adults with cancer.

A new study, published in JAMA Oncology has identified a widespread gap in counseling services for patients who undergo BRCA testing.